Jul 26, 2017Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common StockJuly 26, 2017 at 7:30 PM EDT WESTLAKE VILLAGE, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA)...
Jul 24, 2017eFFECTOR Therapeutics Completes $38.6 Million Series C FinancingJuly 24, 2017 – eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators for the treatment of cancer,...